LIEBMAN SEYMOUR 4
4 · T2 Biosystems, Inc. · Filed Jan 3, 2020
Insider Transaction Report
Form 4
LIEBMAN SEYMOUR
Director
Transactions
- Award
Restricted Stock Units
2020-01-01+34,188→ 34,188 total→ Common Stock (34,188 underlying) - Exercise/Conversion
Common Stock
2020-01-01+13,289→ 49.997 total - Exercise/Conversion
Restricted Stock Units
2020-01-01+13,289→ 13,289 total→ Common Stock (13,289 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]The restricted stock units were granted in accordance with the Issuer's Non-Employee Director Compensation Plan and vest on January 1, 2021.
- [F3]On January 1, 2019 the reporting person was granted 13,289 restricted stock units that vested on January 1, 2020.